Share on Pinterest Weight loss drugs could help improve health outcomes in people with heart failure. The Good Brigade/Getty Images Researchers report that the weight loss drugs semaglutide and ...

Adding to a growing body of research about the related health benefits of diabetes weight-loss drugs, an August 31 study in the Journal of the American Medical Association found that semaglutide and ...

Commonly used medications and nutritional supplements may cause or worsen heart failure, according to the first scientific statement from the American Heart Association to provide guidance on avoiding ...

New drugs and a growing awareness of the common condition offer hope for patients. By Nina Agrawal Ann Ramirez first noticed something was wrong when, at age 48, she started waking up in the middle of ...

ROCKVILLE, Md., Aug. 14 -- The makers of rosiglitazone (Avandia) and pioglitazone (Actos), have agreed to add a black box warning to the type 2 diabetes drugs' labels about an increased risk of heart ...

Myqorzo’s success in “non-obstructive” hypertrophic cardiomyopathy separates it from Bristol Myers Squibb’s rival Camzyos and ...

GLP-1 weight loss drugs containing tirzepatide (Mounjaro, Zepbound) can reduce heart-related health risks for people with ...

Sacubitril-valsartan, a common drug combination for heart failure, cuts the risk for cardiomyopathy after chemotherapy in patients who received anthracycline drugs by 77% in the first randomized ...

The AHA IMPLEMENT-EF initiative launched a pharmacy-led cohort to identify and address medication management gaps in patients with HFpEF and HFmrEF.

A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research from the University of East Anglia. Many cancer patients go on to develop ...